California-based Ikänik Farms Inc. has partnered with CAS Biotechnology to study the effects of pharmaceutical-grade cannabis oil in the treatment of COVID-19.
Under the collaboration deal, Ikänik opted to export the pharmaceutical-grade cannabis provided by its Colombia-based GACP and GMP-Pharma certified Casa Flores facility to Mexico.
The company said Monday that CAS Biotechnology's team would be responsible for testing samples provided by Pideka SAS.
The Mexico-based CAS Biotechnology will oversee scientific research and pre-clinical trials to evaluate the effect of Cannabis oil on SARS-CoV-2's replication cycle.
Ikänik International's President Borja Sanz de Madrid is thrilled with the new partnership while hoping to "aid in the treatment of COVID-19."
"We are very proud to participate in a study that brings medicine and cannabis closer together, in a joint effort to discover possible Phyto therapeutic treatments, as a new course of action for the treatment of COVID-19," Ikänik CEO Brian Baca said.
Earlier this month, the company acquired Delta 9 Corporation Mexico in order to export hemp and cannabis products to Mexico legally.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!